alreadi
caus
death
worldwid
character
distinct
pattern
diseas
progress
impli
divers
host
immun
respons
howev
immunolog
featur
molecular
mechan
involv
sever
remain
far
poorli
known
perform
integr
immun
analysi
includ
indepth
phenotyp
profil
immun
cell
wholeblood
transcriptom
cytokin
quantif
cohort
fifti
patient
spectrum
diseas
sever
patient
test
day
follow
first
symptom
absenc
antiinflammatori
therapi
result
uniqu
phenotyp
sever
critic
ill
patient
identifi
consist
profoundli
impair
interferon
ifn
type
respons
character
low
interferon
product
activ
consequ
downregul
interferonstimul
gene
associ
persist
blood
viru
load
exacerb
inflammatori
respons
partial
driven
transcript
factor
also
character
increas
tumor
necrosi
factor
tnf
interleukin
il
product
signal
well
increas
innat
immun
chemokin
propos
typei
ifn
defici
blood
hallmark
sever
could
identifi
defin
highrisk
popul
studi
provid
rational
test
ifn
administr
combin
adapt
antiinflammatori
therapi
target
sever
patient
data
also
rais
concern
util
drug
interfer
ifn
pathway
earli
clinic
descript
first
coronaviru
diseas
case
end
rapidli
highlight
distinct
pattern
diseas
progress
although
patient
experi
mildtomoder
diseas
progress
sever
critic
diseas
includ
pneumonia
acut
respiratori
failur
base
data
patient
laboratoryconfirm
mainland
china
admiss
intens
care
unit
icu
invas
mechan
ventil
death
occur
case
proport
critic
case
higher
estim
season
influenza
addit
rel
high
rate
respiratori
failur
report
young
adult
age
year
lower
previous
mild
comorbid
hypertens
diabet
mellitu
overweight
sever
case
clinic
observ
typic
describ
twostep
diseas
progress
start
mildtomoder
present
follow
secondari
respiratori
worsen
day
onset
first
symptom
respiratori
deterior
concomit
extens
groundglass
lung
opac
chest
comput
tomographi
ct
scan
lymphocytopenia
high
prothrombin
time
ddimer
level
biphas
evolut
mark
dramat
increas
acut
phase
reactant
blood
suggest
dysregul
inflammatori
host
respons
result
imbal
proand
antiinflammatori
mediat
lead
subsequ
recruit
accumul
leukocyt
tissu
caus
acut
respiratori
distress
syndrom
ard
howev
littl
known
immunolog
featur
molecular
mechan
involv
sever
test
hypothesi
virallydriven
hyperinflamm
lead
sever
diseas
employ
integr
approach
base
clinic
biolog
data
indepth
phenotyp
analysi
immun
cell
standard
wholeblood
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
transcriptom
analysi
cytokin
measur
group
fifti
patient
variabl
sever
mild
critic
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
fifti
patient
diagnosi
accord
interim
guidanc
posit
rtpcr
test
respiratori
sampl
nasopharyng
swab
invas
respiratori
sampl
includ
nonintervent
studi
inpati
preexist
unstabl
chronic
disord
uncontrol
diabet
mellitu
sever
obes
defin
bodi
mass
index
greater
unstabl
chronic
respiratori
diseas
chronic
heart
diseas
exclud
sinc
median
durat
onset
symptom
respiratori
failur
previous
shown
interquartil
rang
day
analyz
immun
signatur
day
first
symptom
patient
initi
antiinflammatori
treatment
healthi
control
asymptomat
adult
match
case
age
neg
rtpcr
test
time
inclus
studi
conform
principl
outlin
declar
helsinki
receiv
approv
appropri
institut
review
board
cochinport
royal
hospit
pari
franc
sever
classifi
base
adapt
sixth
guidanc
mild
case
defin
mild
clinic
symptom
fever
myalgia
fatigu
diarrhea
sign
pneumonia
thorac
comput
tomographi
ct
scan
moder
case
defin
clinic
symptom
associ
dyspnea
radiolog
find
pneumonia
thorac
ct
scan
requir
maximum
lmin
oxygen
sever
case
defin
respiratori
distress
requir
lmin
oxygen
organ
failur
critic
case
defin
respiratori
failur
requir
mechan
ventil
shock
andor
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
patient
characterist
detail
supplementari
appendix
depict
tabl
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
found
infect
patient
especi
critic
patient
nk
cell
display
signific
increas
express
figur
furthermor
express
exhaustionrel
gene
batf
significantli
increas
diseas
sever
supplementari
figur
final
high
annexinv
express
flow
cytometri
upregul
apoptosisrel
gene
blood
sever
critic
patient
support
lymphocytopenia
could
partli
explain
increas
cell
apoptosi
supplementari
figur
investig
immunolog
transcript
signatur
character
diseas
sever
quantifi
express
immunologyrel
gene
blood
cell
figur
identifi
differenti
express
gene
function
sever
grade
figur
unsupervis
princip
compon
analysi
pca
separ
patient
high
diseas
sever
princip
compon
driven
inflammatori
innat
immun
respons
encod
gene
gsea
enrich
score
qvalu
figur
enrich
gene
encod
protein
involv
type
type
ii
interferon
ifn
respons
distinguish
mildtomoder
patient
group
collect
data
suggest
sever
gradedepend
increas
activ
innat
inflammatori
pathway
contrast
ifn
respons
high
mildtomoder
patient
reduc
sever
patient
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
type
ifn
essenti
antivir
immun
multiplex
gene
express
analysi
show
upregul
gene
involv
type
ifn
signal
contrast
strike
downregul
interferonstimul
gene
isg
critic
patient
figur
accordingli
isg
score
base
express
isg
defin
type
ifn
signatur
significantli
reduc
critic
compar
mildtomoder
patient
figur
supplementari
figur
consist
plasma
level
protein
measur
simoa
digit
elisa
significantli
lower
critic
mildtomoder
patient
figur
correl
isg
r
figur
undetect
patient
data
shown
assess
global
type
ifn
activ
vitro
cytopath
assay
use
ifn
activ
serum
significantli
lower
sever
critic
mildtomoder
patient
figur
note
plasmacytoid
dendrit
cell
main
sourc
reduc
infect
patient
compar
control
differ
group
figur
final
evalu
respons
whole
blood
cell
stimul
increas
isg
score
upon
stimul
observ
similar
infect
patient
sever
control
figur
indic
potenti
respons
type
ifn
impact
critic
ill
patient
possibl
consequ
impair
product
observ
increas
plasma
viral
load
possibl
surrog
marker
uncontrol
lung
infect
sever
critic
compar
mildtomoder
patient
viral
load
nasal
swab
compar
group
figur
overal
data
suggest
patient
sever
critic
impair
type
ifn
product
lower
viral
clearanc
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
dissect
mechan
hyperinflamm
sever
critic
patient
sever
report
induc
cytokin
storm
cytokin
chemokinerel
gene
found
increasingli
express
function
diseas
sever
studi
cohort
figur
supplementari
figur
interestingli
cytokin
whole
blood
rna
level
alway
correl
protein
plasma
level
key
player
cytokin
storm
figur
activ
form
protein
low
figur
suggest
poorli
cleav
secret
inflammasom
activ
could
main
player
cytokin
storm
circul
also
detect
data
shown
find
contrast
detect
high
level
circul
receptor
antagonist
upregul
transcript
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
cytokin
storm
associ
massiv
influx
innat
immun
cell
name
neutrophil
monocyt
may
aggrav
lung
injuri
precipit
ard
therefor
analyz
express
chemokin
chemokin
receptor
involv
traffick
innat
immun
cell
figur
neutrophil
chemokin
detect
serum
differ
group
receptor
significantli
upregul
sever
critic
patient
figur
accordingli
sever
diseas
accompani
higher
neutrophilia
monocyt
chemotact
factor
increas
blood
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
infect
patient
well
transcript
receptor
associ
low
circul
inflammatori
monocyt
figur
suggest
role
axi
monocyt
chemoattract
inflam
lung
observ
accord
recent
publish
studi
bronchoalveolar
fluid
patient
describ
key
role
monocyt
overal
result
support
framework
wherebi
ongo
inflammatori
cascad
initi
impair
type
ifn
product
may
fuel
pamp
damp
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
studi
identifi
impair
type
ifn
respons
associ
high
blood
viral
load
sever
critic
patient
invers
correl
excess
inflammatori
respons
associ
increas
coronavirus
also
inhibit
multipl
stage
translat
initi
sever
hypothes
may
propos
explain
interindividu
variabl
ifn
respons
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
studi
confirm
play
import
role
pathogenesi
sever
base
promis
case
seri
random
trial
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
current
evalu
benefit
target
therapi
studi
also
provid
case
inhibit
tnf
axi
inde
tnf
highli
express
alveolar
macrophag
antitnf
block
immun
respons
anim
model
viru
infect
moreov
tnf
blockad
induc
signific
express
reduct
target
could
also
consid
chemokin
antagonist
block
migrat
monocyt
neutrophil
inflam
lung
base
studi
propos
type
ifn
defici
hallmark
sever
infer
sever
critic
patient
could
potenti
reliev
ifn
defici
ifn
administr
exacerb
inflamm
adapt
antiinflammatori
therapi
target
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
contributor
jh
ny
dd
frl
sk
bt
idea
design
studi
full
access
data
studi
take
respons
integr
data
accuraci
data
analysi
jh
ny
af
dd
frl
sk
bt
draft
paper
jh
ny
lb
ac
jb
dd
frl
sk
bt
analysi
author
critic
revis
manuscript
import
intellectu
content
gave
final
approv
version
publish
author
agre
account
aspect
work
ensur
question
relat
accuraci
integr
part
work
appropri
investig
resolv
declar
compet
interest
studi
support
fond
immunov
innov
immunopatholog
studi
also
support
institut
nation
de
la
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
legendr
jonathan
marey
alexi
thank
dr
gaudin
advic
viral
mechan
thank
patient
support
famili
confid
work
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
cellsml
accord
sever
group
f
isg
score
stimul
whole
blood
cell
uiml
hour
g
viral
load
nasal
swab
estim
rtpcr
express
ct
blood
viral
load
evalu
digit
pcr
bf
result
repres
foldincreas
express
compar
mean
unstimul
control
normal
gapdh
p
valu
determin
kruskalw
test
follow
dunn
posttest
multipl
group
comparison
median
report
p
p
p
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
